-
Lying thin is going to come true! Scientists have found the right way to turn on the body's "fat-burning" switch.
Time of Update: 2020-08-12
our data reveal seduing the previously unknown key to unlocking human functions, which could be significant for people with obesity or type 2 diabetes." in all, this study shows that beta 2-AR is an essential ingredient in the heat production and decomposition of white fat in human BAT cells.
-
HER2 drug market melee! How did The Third Life Seputin break out?
Time of Update: 2020-08-08
Pharmaceutical Network July 30 , the development of anti-HER2 targeted treatment drugs , so that HER2-positive breast cancer patients have a significant improvement in the overall prognosis . at pres
-
Important Tips for the CDC! COVID-19 mild, not what you think.
Time of Update: 2020-08-06
Read: The latest study from the CDC COVID-19 Morbidity and Mortality Weekly suggests that patients with MILD COVID-19 infection may have a long time to recover! Currently, there are more than 16.6 mil
-
INOVIO's DNA drug INO-3107 for the treatment of the rare disease RRP was qualified by the FDA for orphan drug.
Time of Update: 2020-08-06
INOVIO (NASDAQ: INO) today announced that the U.S. Food and Drug Administration (FDA) has granted its DNA drug INO-3107, which is currently being evaluated in a Phase 1/2 clinical trial for the treatment of recurrent respiratory papillomavirus (RRP).
-
Alzheimer's blood test is the highlight of the 2020 AAIC.
Time of Update: 2020-08-06
Read: Tau markers take us one step closer to Alzheimer's disease. a simple blood test for Alzheimer's disease will be a huge step forward for people with Alzheimer's disease and at-risk groups, their
-
Metformin has a new role in repairing brain damage.
Time of Update: 2020-08-06
18, or reduce adverse reactions to glucocorticoids, The Lancet-Diabetes and Endocrinology recently published a study showing that in Phase 2 clinical trials, metformin used in patients with chronic inflammatory diseases can improve metabolic health and reduce the serious side effects of glucocorticoid therapy.
-
Nature's latest research paper: Two new crown vaccines for clinical trials.
Time of Update: 2020-08-06
A single-dose vaccine made from adenovirus and a ChAdOx1 nCoV-19 vaccine for the new coronavirus (SARS-CoV-2) are in clinical trials, both of which have been shown to protect non-human primates from new coronaviruses and prevent the occurrence of new co-op strains, according to two papers published online by nature, the international leading academic journal Nature.
-
Nature: One inoculation provides near-complete protection, and the results of the Johnson and Johnson's new crown vaccine animal experiment sharply.
Time of Update: 2020-08-05
studies have shown that a single dose of vaccine induces a powerful neutralizing antibody response, and after 6 weeks of vaccination, almost all rhesus monkeys are immune to the virus.
-
Johnson and Johnson: The single-dose new coronapneumonia candidate vaccine has a powerful protective effect.
Time of Update: 2020-08-05
According to data published in the journal Nature, preclinical studies have shown that the company's research using adenovirus serotonin 26 (Ad26) vector vaccine can cause a strong immune response (as demonstrated by "neutralizing antibodies"), successfully prevent follow-up infections, and provide complete or near-complete virus protection against non-human primates (NHP) lungs." based on valid data, the first clinical trial of the 1/2a phase candidate vaccine Ad26.COV2.S (conducted in healthy volunteers) has been launched in the United States and Belgium.
-
Johnson & Johnson Stelara receives FDA approval for use in children with moderate to severe plaque psoriasis
Time of Update: 2020-08-05
On July 30, , Johnson and Johnson's Xi'an Jansen announced that the U.S. FDA had approved its anti-inflammatory drug Stelara (ustekinumab, ustenuma) for moderate to severe plaque psoriasis (PsO) in children (6-11 years old).
-
Directly modify memory, remove fear, and scientists develop non-invasive therapies!
Time of Update: 2020-08-04
"This study is important for understanding how memory works," said Sara Borgomaneri, a researcher in the Department of Psychology at the University of Bologna who the report." it may even lead to the development of new treatments to treat traumatic memories.
-
A run that can't be called a pause Where does the new Chinese medicine end up?
Time of Update: 2020-08-04
Behind grand narrative is not only a reflection of the speed of China's new drug research and development and the global gradual integration, but also the "backwater war" facing China's innovative pharmaceutical companies collectively.
-
Strengthen the combination of industry, research and development and promote the transformation of innovative drug results.
Time of Update: 2020-08-04
she said that the results of the five-year review and approval show that the safety and quality standards of drugs have not been lowered after speeding up the review and approval, but accelerated approval allows a number of clinically urgently needed domestic innovative drugs to be marketed at an early date, which is of great significance to the health of patients and the sound development of China's pharmaceutical industry.
-
Diabetes treatment drug development situation scan.
Time of Update: 2020-08-02
. At the beginning of the 2007 new year, a new drug for the treatment of diabetes attracted the attention of the international medical community, "Miaozi" was born at the Shanghai Drug Institute and The National New Drug Screening Center of the Chinese Academy of Sciences, which was successfully captured by the research team led by Dr. Wang Mingwei of glucagon-like peptide-1 receptor (GLP-1R) small molecular agonists.
-
The development of The Lung Administration System (PDDS) of Traditional Chinese Medicine has become a hot topic.
Time of Update: 2020-08-02
. In the research and development of aerosols, Liao Yonghong introduced, because of the treatment of respiratory disease has a unique advantage: the drug can directly reach the action site, can avoid the first effect of the liver, reduce drug use, reduce or avoid adverse drug adverse reactions , coupled with research and development, production relative to other lung drug system is relatively simple, The research and application of Chinese medicine aerosol (MDI) has made considerable progress.
-
7 scientists from the Department of Life Sciences and Medicine, a member of the Chinese Academy of Sciences in 2007.
Time of Update: 2020-08-02
medical network finishing 2 2007 the election of academicians of the Chinese Academy of Sciences and the election of foreign academicians has been completed. Medical Network finishing In accord
-
Treatment of nAMD Roche Rejure monoanti-glass implant9% of patients achieved a 6-month time interval between administration.
Time of Update: 2020-07-31
, the Phase III Pagoda trial is also evaluating PDS for the treatment of diabetic macular edema and is currently recruiting patients.
-
4 billion injections of large varieties! The Guangdong pharmaceutical company 2.4 new drugs were approved for clinical treatment.
Time of Update: 2020-07-31
China's public medical institutions terminal cephalosporine sales (units: 10,000 yuan) the current domestic market cephalosporine products are injected with cephalosporine sodium, injection with sodium cephalosporinin, injection of cephalosporine sodium / sodium chloride injection, injection with cephalosporine sodium manufacturers as many as 74, the competition is very fierce.
-
Subvert traditional cognition! Scientists have discovered the real cause of "old deafness".
Time of Update: 2020-07-30
On July 20, , researchers at the Eaton-Peabody Laboratory at the Massachusetts Eye and Ear Hospital, affiliated with Harvard Medical School, published their latest findings in Journalof Neuroscience: Age-related hearing impairment is caused by damage to hair cells, the sensory cells of the inner ear that convert sound vibrations into electrical signals and pass them to the brain through the auditory nerve.
-
Moderna Vaccine Phase I clinical data was officially published, neutralizing antibody titer exceeding the amount of recovered patients!
Time of Update: 2020-07-29
Read: NEJM Published the results of the first phase of clinical analysis of mRNA-1273 !---- two months ago, Moderna, a U.S mRNA technology company, said in a statement that its new coronapneumonia (C
